4-Thiazolidinecarboxamide → HCID 76280804, compound
Reaction equation
[CH:1]1([C:4]2[CH:5]=[CH:6][C:7]([C:15]([OH:17])=O)=[N:8][C:9]=2[O:10][CH2:11][CH:12]2[CH2:14][CH2:13]2)[CH2:3][CH2:2]1.[S:18]1[CH2:22][CH:21]([C:23]([NH2:25])=[O:24])[NH:20][CH2:19]1>>[CH:1]1([C:4]2[CH:5]=[CH:6][C:7]([C:15]([N:20]3[CH:21]([C:23]([NH2:25])=[O:24])[CH2:22][S:18][CH2:19]3)=[O:17])=[N:8][C:9]=2[O:10][CH2:11][CH:12]2[CH2:13][CH2:14]2)[CH2:2][CH2:3]1Participants
3
Procedure
The title compound was synthesized in analogy to Example 47 b, using 5-cyclopropyl-6-cyclopropylmethoxy-pyridine-2-carboxylic acid (Example 3 c, 100 mg, 429 μmol) and 4-thiazolidinecarboxamide (CAN 103749-87-7, 62.3 mg, 472 μmol) as starting materials and isolated (114 mg, 77%) as white solid; LC-MS (UV peak area, ESI) 100%, 348.1377 [MH+].
Workup
- customisolated (114 mg, 77%) as white solid
Sources & evidence
- ORD record
- ord-b6df4d90c15b4b1b85de68a7779c03d5
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09303012B2
Reaction notes
Loading…